Company Filing History:
Years Active: 2016
Title: Kathleen Dashner: Innovator in Antiviral Compounds
Introduction
Kathleen Dashner is a notable inventor based in Foster City, CA (US). She has made significant contributions to the field of antiviral compounds, particularly in the development of solid forms of these compounds. Her work is essential in the ongoing fight against viral infections.
Latest Patents
Kathleen Dashner holds 1 patent for her innovative work. The patent describes crystalline solid forms of the anti-HCV compound (S)-isopropyl 2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate, referred to as Compound I. The patent also outlines processes for making and methods for using these crystalline forms, showcasing her innovative approach to antiviral research.
Career Highlights
Kathleen is currently associated with Gilead Pharmasset LLC, where she continues her research and development efforts. Her work at Gilead has positioned her as a key player in the pharmaceutical industry, particularly in the area of antiviral therapies.
Collaborations
Kathleen has collaborated with talented coworkers, including Melissa Jean Casteel and Hyuk-Jun Jung. These collaborations have further enhanced her research and contributed to the advancement of antiviral compounds.
Conclusion
Kathleen Dashner's contributions to the field of antiviral compounds are noteworthy and impactful. Her innovative work continues to play a crucial role in the development of effective antiviral therapies.